ACAD · ISSUER CIK 1070494
ACADIA PHARMACEUTICALS INC
Between Aug 1, 2026 and Oct 29, 2026, 1 ACADIA PHARMACEUTICALS INC insiders reported $0.00 of open-market purchases and $587K of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 1 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$587KInsider selling
−$587KNet open-market
Aug 7, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 202618:00 | Aug 6, 2026from Aug 5, 2026 | ACAD | EVP, CHIEF FINANCIAL OFFICER | S · Sell10b5-1 | $29.16 | −20,141 | 67,828 | -23% | −$587K | ||
| Aug 7, 202618:00 | Aug 6, 2026from Aug 5, 2026 | ACAD | EVP, CHIEF FINANCIAL OFFICER | M · Exercise10b5-1 | $17.84 | +20,141 | 82,120 | +32% | $359K |